Related Experiment Video
Updated: Feb 28, 2026
The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
A structural perspective on the interactions of TRAF6 and Basigin during the onset of melanoma: A molecular dynamics
Ria Biswas1, Semanti Ghosh1, Angshuman Bagchi1
1Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, Nadia, India.
Abstract:
Metastatic melanoma is the most fatal type of skin cancer. The roles of matrix metalloproteinases (MMPs) have well been established in the onset of melanoma. Basigin (BSG) belongs to the immunoglobulin superfamily and is critical for induction of extracellular MMPs during the onset of various cancers including melanoma. Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an E3-ligase that interacts with BSG and mediates its membrane localization, which leads to MMP expression in melanoma cells. This makes TRAF6 a potential therapeutic target in melanoma. We here conducted protein-protein interaction studies on TRAF6 and BSG to get molecular level insights of the reactions. The structure of human BSG was constructed by protein threading. Molecular-docking method was applied to develop the TRAF6-BSG complex. The refined docked complex was further optimized by molecular dynamics simulations. Results from binding free energy, surface properties, and electrostatic interaction analysis indicate that Lys340 and Glu417 of TRAF6 play as the anchor residues in the protein interaction interface. The current study will be helpful in designing specific modulators of TRAF6 to control melanoma metastasis.
Insights
This study reveals key interactions between TRAF6 and Basigin (BSG) in melanoma. Identifying anchor residues Lys340 and Glu417 in TRAF6 offers new therapeutic targets for controlling metastatic melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Metastatic melanoma is a deadly skin cancer.
- Matrix metalloproteinases (MMPs) are crucial in melanoma development.
- Basigin (BSG) induces MMPs in cancers, including melanoma.
Purpose of the Study:
- To investigate the protein-protein interactions between TRAF6 and BSG at a molecular level.
- To identify potential therapeutic targets for melanoma treatment by understanding the TRAF6-BSG complex.
Main Methods:
- Protein threading was used to construct the human BSG structure.
- Molecular docking simulated the TRAF6-BSG complex formation.
- Molecular dynamics simulations refined the complex and analyzed interactions.
Main Results:
- The study identified Lys340 and Glu417 of TRAF6 as critical anchor residues in the TRAF6-BSG interaction interface.
- Analysis of binding free energy, surface properties, and electrostatic interactions confirmed these key residues.
Conclusions:
- TRAF6 is a potential therapeutic target in melanoma due to its interaction with BSG.
- Understanding the molecular details of TRAF6-BSG interaction can guide the design of specific melanoma metastasis inhibitors.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...